Verity Solution's Purchase Analytics Product Overview

3
©2016 Verity Solutions Group, Inc.– Confidential & Proprietary Product Overview Purchase Analytics

Transcript of Verity Solution's Purchase Analytics Product Overview

Page 1: Verity Solution's Purchase Analytics Product Overview

©2016 Verity Solutions Group, Inc.– Confidential & Proprietary

Product OverviewPurchase Analytics

Page 2: Verity Solution's Purchase Analytics Product Overview

©2016 Verity Solutions Group, Inc.– Confidential & Proprietary

Verity 340BTM Purchase Analytics

Verity Solutions_2

Verity 340BTM Purchase Analytics identifies the optimal NDC mix for significant savings opportunities. By pro-actively monitoring and analyzing NDC opportunities, Purchase Analytics delivers dynamic insight into your data. Your procurement and purchasing team is able to make quick and data-driven purchasing decisions creating an average savings of 10-13% of total drug spend

Enhances any existing 340B Program, regardless of which Third Party Administrator you use

Rapid Implementation

No staff resources required to implement or operate, Verity experts manage the program for you

Cloud-based – no software to download or maintain

Built-in business rule and price trends

Complimentary spend analysis uses your actual purchase history so you can see the savings potential before you buy

Page 3: Verity Solution's Purchase Analytics Product Overview

©2016 Verity Solutions Group, Inc.– Confidential & Proprietary

340B Spend Optimization With over 100,000 NDC’s, it is nearly impossible for Covered Entities to do this

analysis manually, with the exception of a few high-value drugs.

340B Prices change every quarter, therefore any analysis is quickly out of date. Without an automated solution, Covered Entities miss 66.5% of savings opportunities.

There are roughly 32,000 items in the 340B price file for a given quarter (A distributor may stock up to 22,000)

All of the distributors ordering systems have the ability to find the lowest priced item within a drug class, but this does not prioritize the changes based on utilization.

This is a solution that provides the 340B participant a customized work list that prioritizes the most critical changes

Factors Analyzed on Over 100,000 NDCs Quarterly: o GPO and 340B Pricingo Utilization by Purchase Categoryo Wholesaler Availability of Stock

Which Drug Would You Buy

Statistic GPO 340B Overall Calculation

Drug Utilization 60% 40%

Drug Cost A $1.00 $0.90 .96

Drug Cost B $1.05 $0.75 .93

Calculation Footnote:Drug A= (.60) 1.00 + (.40) 0.90 = .60 + .36 = .96Drug B= (.60) 1.05 + (.40) 0.75 = .63 + .30 = .93

RESULT:Based only on GPO price, you would pick Drug A.Based on price and utilization, you would pick Drug B. Without an automated solution, hospitals miss 66.5% of saving opportunities.

o New Genericso New Brand Name Drugs